GOSH Charity funds University of Edinburgh research into treatment for childhood dementia

Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now
A pioneering new study that could pave the way for a safe and long-lasting treatment for two devastating childhood diseases has been given a £250,000 cash boost, thanks to Great Ormond Street Hospital Children’s Charity’s (GOSH Charity) National Call – the largest UK-wide regular funding scheme dedicated to rare and complex paediatric disease research.

A pioneering new study that could pave the way for a safe and long-lasting treatment for two devastating childhood diseases has been given a £250,000 cash boost, thanks to Great Ormond Street Hospital Children’s Charity’s (GOSH Charity) National Call – the largest UK-wide regular funding scheme dedicated to rare and complex paediatric disease research.

The study, led by Professor Brian Bigger at the University of Edinburgh’s Institute for Regeneration and Repair, will seek to improve the effectiveness of stem cell gene therapy to treat Hunter syndrome and Sanfilippo syndrome type B – two diseases caused by a genetic mutation that means the body can’t produce a vital enzyme, leading to fatal brain damage, and in the worst cases, a life expectancy of fifteen years.

Hide Ad
Hide Ad

The team will build on existing research led by Professor Bigger and part-funded by GOSH Charity in 2014. In the earlier project, Bigger and his team treated the symptoms of Sanfilippo syndrome type A by taking stem cells from the bone marrow and delivering a correct copy of the faulty gene. They then transplanted the cells back into the body to produce the missing enzyme, which is essential for breaking down complex sugar molecules in the brain and nervous system. While this study led to clinical improvements for most patients, only a small proportion of the enzyme enters the brain in current treatment, with the remainder delivered to the rest of the body. Additionally, the conditioning drugs required for a successful procedure – largely given in the form of chemotherapy - can be taxing for patients.

National WorldNational World
National World

Now, the team plans to refine this gene therapy by exploring the use of gentler conditioning for the patient before stem cells are collected. Conditioning via chemotherapy is given to eliminate old stem cells and make room for modified cells – a lengthy process that can be physically and emotionally strenuous for the child and their family. The team will also increase the chance of success following treatment by using methods to help boost the level of enzyme reaching the brain.

There are few treatments currently available for these conditions — which affect around 300 children in the UK and are recognised as forms of childhood dementia — and no treatments exist that can slow down or reverse the impact on the brain. Children diagnosed with the diseases progressively lose motor skills such as walking and eating, miss developmental milestones and can present with behavioural issues.

If successful, this research could lead to a safe and long-lasting treatment for children with Hunter syndrome and Sanfilippo syndrome type B, allowing them to lead a long and healthy life. What’s more, it could pave the way for the development of similar gene therapies for other childhood dementias and potentially also adult dementias.

Hide Ad
Hide Ad

Professor Bigger’s research is one of twelve projects which will this year benefit from £2.8million worth of funding awarded through GOSH Charity’s National Call – the most ever awarded via the scheme, due to the high standard of applications for this round of funding. The successful applicants, who are based at institutions across the UK, will investigate some of the rarest and most difficult to treat childhood diseases, with a view of unlocking breakthroughs in child medicine.  

Professor Brian Bigger, Professor of Advanced Therapeutics at the University of Edinburgh, said:“I am delighted that my research is one of the 12 projects to have been awarded funding from GOSH Charity’s National Call this year. Hunter syndrome and Sanfilippo syndrome are progressive diseases that have an immeasurable impact on both the child and their family. This investment from the National Call will mean that my team and I can move a step closer in developing a treatment for the hundreds of families across the UK and beyond facing the devastating consequences of these conditions.”

Dr Aoife Regan, Director of Impact and Charitable Programmes at GOSH Charity, said:We are absolutely delighted to be awarding £2.8m to 12 paediatric research projects from across the UK after receiving 80 applications for this year’s National Call. 

“As the largest charitable funder of medical research dedicated to paediatrics in the UK, GOSH Charity is committed to supporting projects on a national scale to help shape the future of children’s healthcare. The National Call is a brilliant example of how money raised for the charity can have a profound impact for patients and families at GOSH and right across the UK.” 

Find out more about GOSH Charity’s National Call here

Related topics: